Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells. [PDF]
Hong M, Kedeshian K, Hoffman L, Kita A.
europepmc +1 more source
Baicalin attenuates cisplatin-induced cochlear hair cell damage by modulating the ROS-p38 MAPK signaling pathway. [PDF]
Zhang Q +7 more
europepmc +1 more source
Navigating the Genetic Risk of Chemotherapy-Induced Hearing Loss in the Stria Vascularis. [PDF]
Lazetic T +4 more
europepmc +1 more source
Experimental and Clinical Approaches to Preventing Aminoglycoside-Induced Ototoxicity: A Scoping Review. [PDF]
Zadrożniak M +3 more
europepmc +1 more source
From Ototoxicity to Otoprotection: Mechanism and Protective Strategies in Cisplatin Therapy. [PDF]
Iațentiuc A +11 more
europepmc +1 more source
Determination of a New Biomarker at the Level of Gene Alteration in Cisplatin Ototoxicity. [PDF]
Kızmazoğlu D +7 more
europepmc +1 more source
Establishment of a human inner ear model reveals that gentamicin C2b is substantially less ototoxic than clinical gentamicin. [PDF]
Jeong M +4 more
europepmc +1 more source
Sex differences in response to kanamycin-induced ototoxicity in C57BL/6 J mice. [PDF]
Smith-Cortinez N +4 more
europepmc +1 more source
Nigella Sativa and Thymoquinone for Prevention or Mitigation of Acquired Sensorineural Hearing Loss: A Systematic Review. [PDF]
Horvath HL +5 more
europepmc +1 more source
Animal Research in Otorhinolaryngology: Shifts in Publication and Practice Over Two Time Periods. [PDF]
Kısa A.
europepmc +1 more source

